JPY 920.0
(-1.6%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 691 Million | -613 Million | -101 Million | 2.43 Billion | 1.22 Billion | 2.34 Billion |
Net Income | 217 Million | 537 Million | 1.2 Billion | 2.28 Billion | 1.49 Billion | 1.99 Billion |
Depreciation & Amortization | 8 Million | 8 Million | 9 Million | 9 Million | 8 Million | 8 Million |
Deferred income taxes | - | - | - | -573 Million | -948 Million | -512 Million |
Stock-based compensation | - | - | - | 77 Million | 103 Million | 103 Million |
Change in working capital | 206 Million | -812 Million | 38 Million | 419 Million | 569 Million | 771 Million |
Other non-cash items | 259 Million | -346 Million | -1.35 Billion | 211 Million | 6 Million | -14 Million |
Investing Cash Flow | -16 Million | 101 Million | -541 Million | -55 Million | -10 Million | -38 Million |
Investments in PPE | -4 Million | -1 Million | - | -1 Million | -5 Million | - |
Acquisitions | - | - | - | -32 Million | 5 Million | - |
Investment purchases | -1.7 Billion | -1.62 Billion | -1.4 Billion | -320 Million | -330 Million | -337 Million |
Sales/Maturities of investments | 1.67 Billion | 1.62 Billion | 887 Million | 319 Million | 325 Million | 332 Million |
Other Investing Activities | 22 Million | 99 Million | -24 Million | -21 Million | -5 Million | -33 Million |
Financing Cash Flow | 582 Million | -151 Million | -1.18 Billion | -182 Million | -176 Million | 39 Million |
Debt repayment | -1 Million | - | - | -1 Million | -1 Million | -1 Million |
Dividends payments | -93 Million | -93 Million | -101 Million | -101 Million | -101 Million | -98 Million |
Common Stock Repurchased | -235 Million | - | -1.08 Billion | -85 Million | -87 Million | -42 Million |
Common Stock Issuance | 852 Million | 4 Million | - | 6 Million | 1 Million | 14 Million |
Other Financing Activities | 60 Million | -62 Million | -2 Million | -1 Million | 12 Million | 166 Million |
Accounts receivables | 119 Million | 154 Million | 441 Million | 201 Million | -305 Million | -510 Million |
Accounts payables | -110 Million | -1.03 Billion | -313 Million | -78 Million | 487 Million | 664 Million |
Inventory | 8 Million | -22 Million | 3 Million | -12 Million | -2 Million | -2 Million |
Other working capital | 189 Million | 86 Million | -93 Million | 308 Million | 389 Million | 619 Million |
Cash at beginning of period | 8.74 Billion | 9.33 Billion | 11.04 Billion | 8.8 Billion | 7.79 Billion | 5.43 Billion |
Cash at end of period | 10.24 Billion | 8.74 Billion | 9.33 Billion | 11.04 Billion | 8.8 Billion | 7.79 Billion |
Capital Expenditure | -4 Million | -1 Million | - | -1 Million | -5 Million | - |
Effect of forex changes on cash | 242 Million | 68 Million | 121 Million | 41 Million | -27 Million | 10 Million |
Net cash flow / Change in cash | 1.5 Billion | -594 Million | -1.7 Billion | 2.23 Billion | 1.01 Billion | 2.36 Billion |
Free Cash Flow | 687 Million | -614 Million | -101 Million | 2.43 Billion | 1.22 Billion | 2.34 Billion |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 187 Million | 160 Million | 217 Million | 14 Million | 18 Million | 25 Million |
Depreciation & Amortization | - | - | 8 Million | 2 Million | 2 Million | 2 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 206 Million | - | - | - |
Other non-cash items | -187 Million | -160 Million | 259 Million | -14 Million | -18 Million | -25 Million |
Investing Cash Flow | - | - | -16 Million | - | - | - |
Investments in PPE | - | - | -4 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -1.7 Billion | - | - | - |
Sales/Maturities of investments | - | - | 1.67 Billion | - | - | - |
Other Investing Activities | - | - | 22 Million | - | - | - |
Financing Cash Flow | - | - | 582 Million | - | - | - |
Debt repayment | - | - | -1 Million | - | - | - |
Dividends payments | - | - | -93 Million | - | - | - |
Common Stock Repurchased | - | - | -235 Million | - | - | - |
Common Stock Issuance | - | - | 852 Million | - | - | - |
Other Financing Activities | - | - | 60 Million | - | - | - |
Accounts receivables | - | - | 119 Million | - | - | - |
Accounts payables | - | - | -110 Million | - | - | - |
Inventory | - | - | 8 Million | - | - | - |
Other working capital | - | - | 189 Million | - | - | - |
Cash at beginning of period | - | - | 8.74 Billion | 9.98 Billion | 11.16 Billion | 8.74 Billion |
Cash at end of period | - | - | 10.24 Billion | 11.21 Billion | 9.98 Billion | 11.16 Billion |
Capital Expenditure | - | - | -4 Million | - | - | - |
Effect of forex changes on cash | - | - | 242 Million | - | - | - |
Net cash flow / Change in cash | - | - | 1.5 Billion | 1.22 Billion | -1.17 Billion | 2.42 Billion |
Free Cash Flow | - | - | 687 Million | 4 Million | 4 Million | 4 Million |
688663
0RV4
NSRGY
STE
MMWL
DDS